 |
|
A case of malignant hyperthermia during anesthesia induction with sevoflurane -A case report-
Yoon Sook Lee, Woon Young Kim, Se Hwa Lee, Sung Moon Baek, Se Jin Ok, Jae Hwan Kim, Young Cheol Park
Korean J Anesthesiol. 2010;59(Suppl):S6-S8. Published online 2010 Dec 31 DOI: https://doi.org/10.4097/kjae.2010.59.S.S6
|
|
Citations to this article as recorded by
 Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy
Masaki Nakano, Michitaka Funayama, Taketo Takata, Riko Wakisaka, Genki Koyama, Akihiro Koreki, Takuto Ishida, Hiroyuki Uchida, Masaru Mimura
BMC Psychiatry.2024;[Epub] CrossRef Perioperative management in a malignant hyperthermia susceptible patient
RatnaFarida Soenarto, AinoNindya Auerkari, FildzaSasri Peddyandhari, Claudia Lunaesti, AhmadJabir Rahyussalim
Bali Journal of Anesthesiology.2019; 3(3): 178. CrossRef Pharmacogenetics and pathophysiology ofCACNA1Smutations in malignant hyperthermia
Teresa A. Beam, Emily F. Loudermilk, David F. Kisor
Physiological Genomics.2017; 49(2): 81. CrossRef A Minimal-Invasive Metabolic Test Detects Malignant Hyperthermia Susceptibility in a Patient after Sevoflurane-Induced Metabolic Crisis
Frank Schuster, Stephan Johannsen, Norbert Roewer
Case Reports in Anesthesiology.2013; 2013: 1. CrossRef Malignant Hyperthermia and Idiopathic HyperCKemia
Pashtoon Murtaza Kasi
Case Reports in Medicine.2011; 2011: 1. CrossRef
|